Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study
This 2007 study by Fournier et al. analyzed data from the French E3N cohort to assess breast cancer risk associated with various hormone replacement therapies (HRTs) in postmenopausal women. Over an average follow-up of 8.1 years involving 80,377 women, 2,354 cases of invasive breast cancer were identified. The study found